Novavax Inc said on Monday it ended the third quarter with $334.2 million in cash and cash equivalents, as it prepares to start a delayed U.S.-based late-stage trial of its COVID-19 vaccine candidate ...
Tisch junior Juliana Bell used Campus Cash almost every day, most frequently at Peet’s Coffee and Paulson Center vending ...
Oracle's (ORCL) internal documents showed that the fast-growing cloud business has thin gross profit margins in the past year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback